Yong has more than 20 years of experience in the pharmaceutical industry. Prior to BeiGene, he has been engaged in business development work for AstraZeneca for over 11 years, participating in all key projects during the period, transaction types including product licensing, CSO collaboration, and asset divestment, M&A, and joint venture establishment. He has successfully facilitated various forms of business cooperation and introduced a variety of products through flexible transaction structures. The products include innovative large and small molecular drugs, mature products, traditional Chinese medicine, diagnostic tests, and medical devices covering multiple therapeutical areas.

Prior to this, he also served at UCB and Shanghai Ethypharm in strategy planning, business development, and project management. Yong holds a master’s degree in molecular biology from the Beijing bio-engineering institute and obtained his bachelor of Microbiology from Shandong University.